Abstract
Antimony is an important drug for the treatment of Leishmania parasite infections. In several countries, the emergence of drug-resistant Leishmania species has reduced the effectiveness of this drug. The mechanism of clinical drug resistance is unclear. The aim of this work was to identify mitochondrial proteome alterations associated with resistance against antimonial. A combination of cell fractionation, liquid chromatography-tandem mass spectrometry (LC-MS/MS), and Label-Free Quantification was used to characterize the mitochondrial protein composition of Leishmania tropica field isolates resistant and sensitive to meglumine antimoniate. LC-MS/MS analysis resulted in the identification of about 1200 proteins of the Leishmania tropica mitochondrial proteome. Various criteria were used to allocate about 40% proteins to mitochondrial proteome. Comparative quantitative proteomic analysis of the sensitive and the resistant strains showed proteins with differential abundance in resistance species are involved in TCA and aerobic respiration enzymes, stress proteins, lipid metabolism enzymes, and translation. These results showed that the mechanism of antimony resistance in Leishmania spp. field isolate may be associated with alteration in enzymes involved in mitochondrial pathways.
Similar content being viewed by others
References
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. Nat Genet 25(1):25–29
Badirzadeh A, Mohebali M, Ghasemian M, Amini H, Zarei Z, Akhoundi B, Hajjaran H, Emdadi D, Molaei S, Kusha A, Alizadeh S (2013) Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series. Pathogens Glob Health 107(4):194–197
Badirzadeh A et al (2017) The burden of leishmaniasis in Iran, acquired from the global burden of disease during 1990-2010. Asian Pac J Trop Dis 7(9):513–518
Berg M et al (2015) Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations. Antimicrob Agents Chemother 59(4): 2242–2255
Biyani N, Singh AK, Mandal S, Chawla B, Madhubala R (2011) Differential expression of proteins in antimony-susceptible and-resistant isolates of Leishmania donovani. Mol Biochem Parasitol 179(2):91–99
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1–2):248–254
Braly P, Simpson L, Kretzer F (1974) Isolation of kinetoplast-mitochondrial complexes from Leishmania tarentolae. J Eukaryot Microbiol 21(5):782–790
Brochu C, Haimeur A, Ouellette M (2004) The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania. Cell Stress Chaperones 9(3):294–303
Brotherton M-C et al (2013) Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant. PLoS One 8(11):e81899
Brotherton M-C, Bourassa S, Légaré D, Poirier GG, Droit A, Ouellette M (2014) Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum. Int J Parasitol Drugs Drug Resist 4(2):126–132
Chawla B, Jhingran A, Panigrahi A, Stuart KD, Madhubala R (2011) Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin–susceptible–resistant Leishmania donovani. PLoS One 6(10):e26660
Cottrell JS, London U (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18):3551–3567
Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26(12):1367–1372
Cruz-Bustos T, Ibarrola-Vannucci AK, Díaz-Lozano I, Ramírez JL, Osuna A (2018) Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major. Parasit Vectors 11(1):622
Das M, Saudagar P, Sundar S, Dubey VK (2013) Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species. FEBS J 280(19):4807–4815
Ferro M, Salvi D, Brugière S, Miras S, Kowalski S, Louwagie M, Garin J, Joyard J, Rolland N (2003) Proteomics of the chloroplast envelope membranes from Arabidopsis thaliana. Mol Cell Proteomics 2(5):325–345
Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts. Nat Protoc 2(2):287–295
Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK (1994) Heat shock proteins and drug resistance. Breast Cancer Res Treat 32(1):67–71
Gazanion É, Fernández-Prada C, Papadopoulou B, Leprohon P, Ouellette M (2016) Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania. Proc Natl Acad Sci U S A 113(21):E3012–E3021
Gonçalves RL, Barreto RFM, Polycarpo CR, Gadelha FR, Castro SL, Oliveira MF (2011) A comparative assessment of mitochondrial function in epimastigotes and bloodstream trypomastigotes of Trypanosoma cruzi. J Bioenerg Biomembr 43(6):651–661
Guerra F, Arbini AA, Moro L (2017) Mitochondria and cancer chemoresistance. Biochim Biophys Acta Bioenerg 1858(8):686–699
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3(5):e162
Hajjaran H et al (2013) Molecular identification and polymorphism determination of cutaneous and visceral leishmaniasis agents isolated from human and animal hosts in Iran. Biomed Res Int 2013: 789326
Hanada K (2003) Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta Mol Cell Biol Lipids 1632(1–3):16–30
Harder S, Bente M, Isermann K, Bruchhaus I (2006) Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani. Eukaryot Cell 5(5):861–870
Ibrahim M, Gahoual R, Enkler L, Becker HD, Chicher J, Hammann P, François YN, Kuhn L, Leize-Wagner E (2016) Improvement of mitochondria extract from Saccharomyces cerevisiae characterization in shotgun proteomics using sheathless capillary electrophoresis coupled to tandem mass spectrometry. J Chromatogr Sci 54(4):653–663
Jeddi F, Piarroux R, Mary C (2011) Antimony resistance in Leishmania, focusing on experimental research. J Trop Med 2011: 695382
Jeffers V et al (2017) TgPRELID, a mitochondrial protein linked to multidrug resistance in the parasite toxoplasma gondii. mSphere 2(1):e00229–e00216
Jin L et al (2014) Down-regulation of Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines. Mol Cell Proteomics M113:033217
Käll L, Canterbury JD, Weston J, Noble WS, MacCoss MJ (2007) Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 4(11):923–925
Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Abedkhojasteh H, Heidari M (2013) Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol 135(2):344–349
Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6(5):513–519
Link AJ (1999) 2-D proteome analysis protocols, vol 112. Springer Science & Business Media, Berlin
Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180(2):564–567
Mailloux RJ, Bériault R, Lemire J, Singh R, Chénier DR, Hamel RD, Appanna VD (2007) The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One 2(8):e690
Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M (2005) Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol 57(6):1690–1699
Masoori L, Kheirandish F, Haghighi A, Mohebali M, Akhoundi B, Taghipour N, Gachkar L, Chegeni-Sharafi A, Moin-Vaziri V (2018) Molecular-based detection of Leishmania infantum in human blood samples in a new focus of visceral Leishmaniasis in Lorestan Province, Iran. J Arthropod Borne Dis 12(1):67–75
Mathur R, Das RP, Ranjan A, Shaha C (2015) Elevated ergosterol protects Leishmania parasites against antimony-generated stress. FASEB J 29(10):4201–4213
Matrangolo FS, Liarte DB, Andrade LC, de Melo MF, Andrade JM, Ferreira RF, Santiago AS, Pirovani CP, Silva-Pereira RA, Murta SM (2013) Comparative proteomic analysis of antimony-resistant and-susceptible Leishmania braziliensis and Leishmania infantum chagasi lines. Mol Biochem Parasitol 190(2):63–75
Messaritakis I, Christodoulou V, Mazeris A, Koutala E, Vlahou A, Papadogiorgaki S, Antoniou M (2013) Drug resistance in natural isolates of Leishmania donovani sl promastigotes is dependent of Pgp170 expression. PLoS One 8(6):e65467
Michels P, Hannaert V, Bringaud F (2000) Metabolic aspects of glycosomes in Trypanosomatidae–new data and views. Parasitol Today 16(11):482–489
Millerioux Y, Morand P, Biran M, Mazet M, Moreau P, Wargnies M, Ebikeme C, Deramchia K, Gales L, Portais JC, Boshart M, Franconi JM, Bringaud F (2012) ATP synthesis-coupled and-uncoupled acetate production from acetyl-CoA by mitochondrial acetate: succinate CoA-transferase and acetyl-CoA thioesterase in Trypanosoma. J Biol Chem 287(21):17186–17197
Moreira W, Leprohon P, Ouellette M (2011) Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis 2(9):e201
Opperdoes FR, Coombs GH (2007) Metabolism of Leishmania: proven and predicted. Trends Parasitol 23(4):149–158
Opperdoes FR, Michels PA (2008) Complex I of Trypanosomatidae: does it exist? Trends Parasitol 24(7):310–317
Palmfeldt J, Bross P (2017) Proteomics of human mitochondria. Mitochondrion 33:2–14
Palmieri F, Pierri CL, De Grassi A, Nunes-Nesi A, Fernie AR (2011) Evolution, structure and function of mitochondrial carriers: a review with new insights. Plant J 66(1):161–181
Panigrahi AK, Ogata Y, Zíková A, Anupama A, Dalley RA, Acestor N, Myler PJ, Stuart KD (2009) A comprehensive analysis of Trypanosoma brucei mitochondrial proteome. Proteomics 9(2):434–450
Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, López-Vélez R, García-Hernández R, Pountain AW, Mwenechanya R, Papadopoulou B (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl Trop Dis 11(12):e0006052
Priest JW, Hajduk S (1992) Cytochrome c reductase purified from Crithidia fasciculata contains an atypical cytochrome c1. J Biol Chem 267(28):20188–20195
Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, de T, Singh D, Das P (2012) Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother 56(2):1031–1041
Rai S, Goel SK, Dwivedi UN, Sundar S, Goyal N (2013) Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani. PLoS One 8(9):e74862
Rivière L et al (2009) Acetate produced in the mitochondrion is the essential precursor for lipid biosynthesis in procyclic trypanosomes. Proc Natl Acad Sci 106(31):12694–12699
Roy A, Ganguly A, BoseDasgupta S, Das BB, Pal C, Jaisankar P, Majumder HK (2008) Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3, 3′-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol 74(5):1292–1307
Saitou M, Isonishi S, Hamada T, Kiyokawa T, Tachibana T, Ishikawa H, Yasuda M (2009) Mitochondrial ultrastructure-associated chemotherapy response in ovarian cancer. Oncol Rep 21(1):199–204
Sereno D, Holzmuller P, Mangot I, Cuny G, Ouaissi A, Lemesre J-L (2001) Antimonial-mediated DNA fragmentation inLeishmania infantum Amastigotes. Antimicrob Agents Chemother 45(7):2064–2069
Shekari F, Baharvand H, Salekdeh GH (2014) Organellar proteomics of embryonic stem cells advances in protein chemistry and structural biology. 95. Elsevier, p 215-230
Singh S, Dubey VK (2016) Quantitative proteome analysis of Leishmania donovani under spermidine starvation. PLoS One 11(4):e0154262
Sognier MA, Yin Z, Eberle RL, Sweet KM, Altenberg GA, Belli JA (1994) Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48(2):391–401
Soumya N, Kumar IS, Shivaprasad S, Gorakh LN, Dinesh N, Swamy KK, Singh S (2015) AMP-acetyl CoA synthetase from Leishmania donovani: identification and functional analysis of ‘PX4GK’motif. Int J Biol Macromol 75:364–372
Stekhoven DJ, Omasits U, Quebatte M, Dehio C, Ahrens CH (2014) Proteome-wide identification of predominant subcellular protein localizations in a bacterial model organism. J Proteome 99:123–137
Sudhandiran G, Shaha C (2003) Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Biol Chem 278(27):25120–25132
Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H (2008) Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol 28(3):1007–1017
Sundar S, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56(2):143–153
Sundar S, Pai K, Kumar R, Pathak-Tripathi K, Gam AA, Ray M, Kenney RT (2001) Resistance to treatment in Kala-azar: speciation of isolates from Northeast India. Am J Trop Med Hyg 65(3):193–196
Tasbihi M, Shekari F, Hajjaran H, Masoori L, Hadighi R (2019) Mitochondrial proteome profiling of Leishmania tropica. Microb Pathog 133:103542
Tessarollo NG, Andrade JM, Moreira DS, Murta SMF (2015) Functional analysis of iron superoxide dismutase-a in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines. Parasitol Int 64(2):125–129
t’Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S (2010) Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 4(11):e904
Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6(1):88–101
Vincent IM, Racine G, Légaré D, Ouellette M (2015) Mitochondrial proteomics of antimony and miltefosine resistant Leishmania infantum. Proteomes 3(4):328–346
Walker J et al (2012) Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol Biochem Parasitol 183(2):166–176
Wiśniewski JR, Duś K, Mann M (2013) Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins. Proteomics Clin Appl 7(3–4):225–233
Zhang O, Wilson MC, Xu W, Hsu FF, Turk J, Kuhlmann FM, Wang Y, Soong L, Key P, Beverley SM, Zhang K (2009) Degradation of host sphingomyelin is essential for Leishmania virulence. PLoS Pathog 5(12):e1000692
Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 4(3):e532
Acknowledgments
We express our sincere thanks to Dr. Marc Ouellete for proof-reading and revising the final draft of the manuscript.
Funding
This research is a part of Ph.D thesis of first author and was supported by Grant No.28625 from Iran University of Medical Sciences (IUMS), Tehran, Iran.
Author information
Authors and Affiliations
Contributions
1. Conceived and designed the experiments: RH FSH MT HH.
2. Performed the experiments: MT FSH.
3. Analyzed the data: MT FSH RH.
4. Wrote and revised the paper: MT FSH RH MKh.
5. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interests.
Additional information
Section Editor: Sarah Hendrickx
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 155 kb).
Rights and permissions
About this article
Cite this article
Tasbihi, M., Shekari, F., Hajjaran, H. et al. Comparative mitochondrial proteomics of Leishmania tropica clinical isolates resistant and sensitive to meglumine antimoniate. Parasitol Res 119, 1857–1871 (2020). https://doi.org/10.1007/s00436-020-06671-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-020-06671-x